The total cannabis sector of 319 stocks increased 2.3% on Tuesday compared to the new Non-penny Pot Stock Index (NPSI) which advanced 1.6%. 18 of the 34 constituent stocks in the NPSI went up, 4 remained unchanged in value and the remaining 12 went down in price. The details are as follows: 

The 10 Cannabis Stocks That Increased More Than 2.5% 

1. Rubicon Organics (ROMJF) +20.5%
2. Planet 13 (PLNHF) +7.5%
3. Tilray (TLRY) +6.9%
4. GW Pharma (GWPH) +5.9%
5. Medicine Man (MDCL) +5.4%
6. Valens (VLNCF) +5.1%
7. Ayr (AYRSF) +3.7%
8. Akerna (KERN) +3.3%
9. Neptune (NEPT) +2.7%
10. Village Farms (VFF) +2.6%

The 4 Cannabis Stocks That Declined More Than 2.5% 

• Pyxus (PYX) -13.5% 
• New Age (NBEV) -4.3%
• Zynerba (ZYNE) -3.9%
• Cronos (CRON) -2.6%

4 Notable Mentions

• Aphria (APHA) +1.3%
• Canopy Growth (CGC) +1.1%
• Hexo (HEXO) +/-0%
• Aurora (ACB) +/-0%

For the record, as of today:

• 2 pot stocks trade above US$20/share,
• 2 trade between US$10 and US$20/share,
• 7 trade between US$5 and US$10/share and
• 23 trade between US$1 and US$5/share.

In addition, the market capitalization makeup of the NPSI, calculated by multiplying the number of a company's shares outstanding by its stock price per share, is as follows:

• Large-Cap (+US$10B): 0
• Mid-Cap (US$2B to US$10B): 3
• Small-Cap (US$300M to US$2B): 11
• Micro-Cap (US$50M to US$300M): 15
• Nano-Cap (Less than US$50M): 5

To see how the above stocks, and the others that make up the balance of the new Non-penny Pot Stock Index (NPSI), have done on a daily basis over the last 3 weeks, visit my previous articles here.